CHRONIC KIDNEY DISEASE AND ARRHYTHMIAS: CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE-Reference-Cited by-同舟云学术

CHRONIC KIDNEY DISEASE AND ARRHYTHMIAS: CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE

Published:2019-02-21 Issue:2 Volume:23 Page:18-40
ISSN:2541-9439
Container-title:Nephrology (Saint-Petersburg)
language:
Short-container-title:Nefrologiâ (St.-Peterbg.)

Author:

Blankestijn Peter J.¹,Carrero Juan-Jesus²,Clase Catherine M.³,Deo Rajat⁴,Herzog Charles A.⁵,Kasner Scott E.⁶,Passman Rod S.⁷,Pecoits-Filho Roberto⁸,Reinecke Holger⁹,Shrof Gautam R.¹⁰,Zareba Wojciech¹¹,Cheung Michael¹²,Wheeler David C.¹³,Winkelmayer Wolfgang C.¹⁴,Wanner Christoph¹⁵,Turakhia Mintu P.¹⁶

Affiliation:

1. University Medical Center, P.O. Box 85500, 3508GA Utrecht

2. Karolinska Institutet,Nobels va¨g 12A, Box 281, 171 77 Stockholm

3. Department of Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, St.Joseph’s Healthcare, Marian Wing, 3rd Floor, M333, 50 Charlton Ave. E, Hamilton, Ontario L8N 4A6

4. Section of Electrophysiology, Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, 9 Founders Cardiology, Philadelphia, 19104 PA

5. Division of Cardiology,Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota and Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 S. 8th Street, S4.100, Minneapolis, 55404 MN

6. Department of Neurology, 3W Gates Bldg. Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, 19104-4283 PA

7. Northwestern University Feinberg School of Medicine and the Bluhm Cardiovascular Institute, 201 E. Huron St. Chicago, 60611 IL, USA

8. School of Medicine, Pontificia Universidade Catolica do Paraná, Rua Imaculada Conceic¸~ao 1155, 80220-901 Curitiba PR

9. Department für Kardiologie und Angiologie Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Muenster

10. Division of Cardiology, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, 55415 MN

11. Heart Research Follow-up Program, Cardiology Division, University of Rochester Medical Center, Saunders Research Building, 265 Crittenden Blvd. CU 420653, Rochester, 14642 NY

12. KDIGO, Avenue Louise 65, Suite 11, 1050 Brussels

13. Centre for Nephrology, University College London,Rowland Hill Street, London NW3 2PF, UK

14. Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, ABBR R705, MS: 395, Houston, 77030-3411 TX

15. Division of Nephrology, Department of Medicine, University Hospital of Würzburg, Oberduerrbacherstr. 6 Würzburg D-97080

16. Stanford University School of Medicine, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave, 111C, Palo Alto, CA 94304

Abstract

Patients with chronic kidney disease (CKD) are predisposed to heart rhythm disorders, including atrial fibrillation (AF)/atrial flutter, supraventricular tachycardias, ventricular arrhythmias, and sudden cardiac death (SCD). While treatment options, including drug, device, and procedural therapies, are available, their use in the setting of CKD is complex and limited. Patients with CKD and end-stage kidney disease have historically been under-represented or excluded from randomized trials of arrhythmia treatment strategies, 1 although this situation is changing. Cardiovascular society consensus documents have recently identified evidence gaps for treating patients with CKD and heart rhythm disorders. To identify key issues relevant to the optimal prevention, management, and treatment of arrhythmias and their complications in patients with kidney disease, Kidney Disease: Improving Global Outcomes (KDIGO) convened an international, multidisciplinary Controversies Conference in Berlin, Germany, titled CKD and Arrhythmias in October 2016.

Publisher

Non-profit organization Nephrology

Subject

Nephrology

Reference184 articles.

1. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006;70:2021–2030. Doi: https://Doi.org/10.1038/ sj.ki.5001934

2. Konstantinidis I, Nadkarni GN, Yacoub R et al. Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review. JAMA Intern Med 2016;176: 121–124. Doi: https://Doi.org/10.1001/jamainternmed.2015.6102

3. Boriani G, Savelieva I, Dan GA et al. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2015;17: 1169–1196. Doi: https://Doi. org/10.1093/europace/euv202

4. Heidbuchel H, Verhamme P, Alings M et al. Updated European Heart Rhythm Association Practical Guide on the use of nonvitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 2015;17: 1467–1507. Doi: https://Doi. org/10.1093/europace/euv309

5. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–2962. Doi: https://Doi. org/10.1093/ejcts/ezw313

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation in patients with chronic kidney disease: features of pathogenesis and treatment;Cardiac Arrhythmias;2023-09-13

2. Atrial fibrillation and chronic kidney disease: main clinical characteristics of patients in selected subjects of the Russian Federation;Cardiovascular Therapy and Prevention;2023-05-09

3. Prediction of cardiovascular complications and progression of renal failure in pediatric patients with chronic kidney disease according to NKF-K/DOQI (2002) and KDIGO (2012) classifications;Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics);2022-06-07

4. Pediatric problems of stratification of the severity of stages, cardiovascular complications and renal forecast of chronic kidney disease by NKF-K / DOQI (2002) and KDIGO (2012) classifications;Nephrology (Saint-Petersburg);2021-04-23

5. Role of angiotensin-converting enzyme inhibitors in reducing cardiovascular and cerebral complications in chronic kidney disease: focus perindopril;The Clinician;2021-01-26